Northwest Biotherapeutics Company
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Last Funding Type:
Post-IPO Debt
Funding Status:
IPO
Headquarters:
Bethesda, Maryland, United States
Founded Date:
1998-01-01
Last Funding Date:
2021-11-22
Total Funding:
169400000
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Investors Number:
1
Industry:
Dendritic Cells